Stock listing
C4 Therapeutics, Inc.
Selected listing: CCCC · NASDAQ · USD · US
C4 Therapeutics, Inc. (NASDAQ:CCCC), Health Technology. Latest release Sep 25, 2026: C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1…
- Ticker
- NASDAQ:CCCC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About C4 Therapeutics, Inc.
C4 Therapeutics, Inc. (CCCC) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from C4 Therapeutics, Inc.
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting
September 25, 2026
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed, Refractory Multiple Myeloma Trial
September 4, 2026
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting
September 3, 2026
C4 Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
August 11, 2026
C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population
June 10, 2026
Research C4 Therapeutics, Inc.
C4 Therapeutics, Inc. company profile
View the public company page for C4 Therapeutics, Inc. on 6ix.
C4 Therapeutics, Inc. news
Read company news and market updates connected to C4 Therapeutics, Inc..
C4 Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for C4 Therapeutics, Inc..